大博集团品牌怎么样 申请店铺

我要投票 大博集团在男科医院行业中的票数:239 更新时间:2025-06-07
大博集团是哪个国家的品牌?「大博集团」是 大博医疗科技股份有限公司 旗下著名品牌。该品牌发源于福建省厦门市,由创始人林 * 雄在2004年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力大博集团品牌出海!将品牌入驻外推网,定制大博集团品牌推广信息,可以显著提高大博集团产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

大博集团怎么样

成立于2004年,以骨科、神经外科、微创外科为主的综合性医疗集团,与世界各地的专家建立良好的合作关系和经验交流


大博简介

大博医疗科技股份有限公司,成立于2004年,坐落于美丽的鹭岛——厦门,是一家以骨科、神经外科、微创外科为主的综合性医疗集团。公司先后通过了FDA、CE、ISO13485、GMP等专业认证,产品品质不断超越国际标准,得到国内外用户的一致认可。

研发制造

紧密结合临床,是大博开展研发工作的基石。经多年的钻研沉淀,与国内北上广等地的知名专家,以及澳大利亚、瑞士等国际专家,皆建立起良好的合作关系,广纳临床专家的实践经验,坚持不懈地进行产品和技术的提升与创新。同时,大博成立了厦门骨科医疗器械工程技术研究中心、与厦门大学联合成立厦大化工——大博医疗外科材料研发中心、同时还与台湾科技大学合办产学研项目,并承接多个科技项目。引进国际加工设备,以高度机械化的生产工艺,依托科学的质量管理体系,精心打造各种医疗产品,涵盖骨科、齿科、微创外科、神经外科、医用电子、医疗设备等。

营销网络

大博在产品、推广、服务等各方面进行创新,在全国多省均设有物流平台,构建便捷的物流网络。与近千家经销商通力合作,不断提高服务效率,及时地为3500余家医院提供优质的服务。同时,大博设立专业的“咨询服务与技术支持”团队,为客户提供医疗器械使用方法及技术要点咨询服务,解决医师在临床上遇到的困难和问题。“高品质,赢天下”。大博放眼全球,实行国际化战略布局,拥有涵盖英语、俄语、拉丁语等多语种的国际营销部门,产品直接出口至澳大利亚、瑞士、俄罗斯、乌克兰等20多个国家和地区。

发展战略

为配合企业前进的步伐,大博制定了四化发展战略:专业化——专攻医疗产品,只做业内前三;多元化——在医疗领域内实现产品多元化,打造综合性医用高值材料供应商;国际化——国际化发展战略,产品研发销售皆面向国际市场;创新化——产品研发、企业发展立足创新,推出创新性医疗产品,坚持以创新驱动发展企业。进行以产品为核心的研发、制造、教育、推广。


Founded in 2004, a comprehensive medical group focusing on orthopedics, neurosurgery and minimally invasive surgery, established a good cooperation relationship and experience exchange with experts from all over the world. Dabo Medical Technology Co., Ltd., founded in 2004, is located in Xiamen, the beautiful island of heron. It is a comprehensive medical group focusing on orthopedics, neurosurgery and minimally invasive surgery. The company has passed FDA, CE, ISO13485, GMP and other professional certification. The product quality continues to exceed international standards, and has been unanimously recognized by users at home and abroad. R & D and manufacturing are closely combined with clinical practice, which is the cornerstone of Dabo's R & D work. After years of research and precipitation, we have established good cooperation with well-known experts in China, Beijing, Shanghai, Guangzhou and other places, as well as international experts in Australia, Switzerland and other places. We have widely accepted the practical experience of clinical experts, and have been unremitting in product and technology upgrading and innovation. At the same time, Dabo has established Xiamen orthopedic medical device engineering technology research center, Xiamen University and Xiamen University to jointly establish Xiamen University chemical - Dabo medical surgical material research and development center. At the same time, Dabo and Taiwan University of science and technology jointly run production, teaching and research projects, and undertake a number of scientific and technological projects. With the introduction of international processing equipment, highly mechanized production process, and relying on scientific quality management system, we have carefully built various medical products, including orthopedics, dentistry, minimally invasive surgery, neurosurgery, medical electronics, medical equipment, etc. The marketing network is innovative in products, promotion, services and other aspects. It has logistics platforms in many provinces across the country to build a convenient logistics network. Cooperate with nearly 1000 distributors to improve service efficiency and provide quality services to more than 3500 hospitals in a timely manner. At the same time, Dabo has set up a professional "consulting service and technical support" team to provide customers with consulting services on the use methods and technical points of medical devices, so as to solve the clinical difficulties and problems encountered by doctors. "High quality, win the world". Dabo has a global perspective and an international strategic layout. It has an international marketing department covering English, Russian, Latin and other languages. Its products are directly exported to more than 20 countries and regions, including Australia, Switzerland, Russia, Ukraine and so on. Development strategy in line with the pace of enterprise progress, Dabo has formulated four development strategies: Specialization - specializing in medical products, only making the top three in the industry; diversification - realizing product diversification in the medical field, creating comprehensive medical high-value material suppliers; internationalization - international development strategy, product R & D and sales are oriented to the international market; innovation - Product R & D Based on innovation, the development of enterprises will launch innovative medical products and adhere to innovation driven development of enterprises. Carry out R & D, manufacturing, education and promotion with products as the core.

本文链接: https://brand.waitui.com/2fe6bfaf5.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

华晨宝马人事调整:宝思齐将出任总裁兼首席执行官,戴鹤轩返回德国任职

华晨宝马董事会今日宣布人事任命,宝思齐将自2025年8月1日起,接替戴鹤轩出任华晨宝马总裁兼首席执行官;戴鹤轩将于2025年7月31日结束其在中国的任期,返回德国,担任宝马集团首席信息官及信息技术部高级副总裁的新职务。(新浪科技)

7分钟前

孩子王:拟通过控股子公司收购丝域实业100%股权

36氪获悉,孩子王发布公告,公司拟受让关联方五星控股持有的江苏星丝域65%股权。为强化产业协同和资源整合,巨子生物、自然人陈英燕、王德友拟同时受让五星控股持有的江苏星丝域10%、8%及6%的股权,本次股权转让完成后,江苏星丝域将成为公司的控股子公司,鉴于本次股权转让前江苏星丝域的注册资本尚未实缴,且无实际经营活动,本次股权转让中,公司、巨子生物、陈英燕及王德友受让江苏星丝域股权的价格均为0元。另外,公司拟通过江苏星丝域现金收购丝域实业100%股权,转让价格为16.5亿元。交易完成后,公司间接持有丝域实业65%股权,丝域实业将成为公司的控股子公司。

7分钟前

美股大型科技股盘前普涨,特斯拉涨超4%

36氪获悉,美股大型科技股盘前普涨,截至发稿,特斯拉涨超4%,亚马逊涨超2%,谷歌、Meta、英伟达涨超1%,苹果涨0.83%,微软涨0.56%,奈飞涨0.55%。

7分钟前

热门中概股美股盘前多数下跌,新东方跌超2%

36氪获悉,热门中概股美股盘前多数下跌,新东方跌超2%,名创优品、腾讯音乐、网易、蔚来、跌超1%,阿里巴巴跌0.68%,京东跌0.55%,小鹏汽车跌0.55%,百度跌0.41%;理想汽车涨超1%,微博涨0.63%。

7分钟前

香港证监会向持牌法团发出指引,预防客户帐户内的未经授权交易

36氪获悉,据香港证监会网站消息,因应近期骗徒透过仿冒诈骗流动文字讯息中的超连结发动攻击(通常称为短讯仿冒诈骗)的事故有所增加,香港证监会今天向持牌法团发出相关指引,以预防客户帐户内的未经授权交易。

7分钟前

本页详细列出关于大博集团的品牌信息,含品牌所属公司介绍,大博集团所处行业的品牌地位及优势。
咨询